Why has user adoption of Owkin's Collaborative Cancer Research Network declined by 25% among oncologists in the past 6 months?

Introduction

The decline in user adoption of Owkin's Collaborative Cancer Research Network among oncologists by 25% over the past 6 months is a critical issue that demands immediate attention. This analysis will systematically identify, validate, and address the root cause while considering both short-term and long-term implications for the product and its users.

To tackle this problem, I'll employ a structured approach that covers issue identification, hypothesis generation, validation, and solution development. My response will follow a clear agenda, moving from clarifying questions to external factor analysis, product understanding, metric breakdown, data gathering, hypothesis formation, root cause analysis, validation, and finally, a resolution plan.

Step 1

Clarifying Questions (3 minutes)

• Looking at the timing, I'm thinking there might have been a recent product update. Has there been any significant change to the platform in the last 6-8 months?

Why it matters: Product changes can directly impact user behavior and adoption rates. Expected answer: Yes, there was a major UI overhaul about 7 months ago. Impact on approach: If confirmed, we'd focus on usability issues and user feedback related to the new interface.

• Considering the specific user group affected, I'm curious about the oncologist demographics. Has there been any shift in the age or experience level of oncologists using the platform?

Why it matters: Different user segments may have varying needs and adoption rates. Expected answer: We've seen an increase in younger oncologists joining the platform. Impact on approach: If true, we'd investigate whether the platform is meeting the needs of this new user segment.

• Given the collaborative nature of the platform, I'm wondering about network effects. Has there been any change in the number or activity level of research institutions on the platform?

Why it matters: The value of a collaborative network often depends on the active participation of all stakeholders. Expected answer: A few major research institutions have reduced their activity in the past year. Impact on approach: This would lead us to investigate the reasons behind institutional disengagement and its impact on individual oncologists.

• Considering potential external factors, have there been any significant changes in funding or regulatory environment for cancer research in the past year?

Why it matters: External factors can significantly influence research activities and platform usage. Expected answer: There's been a slight decrease in public funding for certain types of cancer research. Impact on approach: We'd need to assess how this external change might be affecting platform usage and consider ways to adapt our value proposition.